349
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience

, , &
Pages 899-904 | Received 15 Apr 2019, Accepted 06 Jun 2019, Published online: 16 Jun 2019
 

Abstract

Background and aims: Accurate estimates of the long-term risks of adverse outcomes after transjugular intrahepatic portosystemic shunt (TIPS) treatment are needed. The aim of this cohort study was to estimate the risks of stent dysfunction, variceal bleeding, refractory ascites, hepatic encephalopathy (HE), and death after TIPS treatment.

Methods: We extracted data from electronic medical records of 104 consecutive TIPS patients. Gore® Viatorr® TIPS endoprostheses were used in all patients. We conducted competing risks analysis of the risk of stent dysfunction and variceal bleeding, and Kaplan–Meier estimation of overall survival.

Results: The overall 1-year survival after TIPS insertion was 82% (95% confidence interval [CI]: 73–88%), and the 1-year risk of stent dysfunction was 15% (95% CI: 9–22%). In patients who had a TIPS for variceal bleeding, the 1-year risk of rebleeding was 23% (95% CI: 13–35%). In patients who had a TIPS for refractory ascites, the risk of having an unsuccessful ascites outcome 1 year after TIPS for refractory ascites was 35% (95% CI: 21–52%). Overall, the 1-year risk of overt HE was 38% (95% CI: 32–43%). The risk of experiencing any of the defined complications during the first year was 56% (95% CI: 45–66%).

Conclusion: TIPS is an effective treatment for variceal bleeding and refractory ascites in most cases, but more than half of the patients experience either death, stent dysfunction, recurrence of symptoms, or overt HE within the first year after the procedure.

Disclosure statement

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.